| 產(chǎn)品名稱 | BH3I 1 - BHI 1 |
| 產(chǎn)品貨號(hào) | Axon 1828 CAS [300817-68-9] MF C15H14BrNO3S2MW 400.31 Purity: 99% Soluble in 0.1N NaOH(aq) and DMSO Description Cell permeable antitumor agent targeting Bcl-2 family protein, more specifically as Bcl-xL antagonist; apoptosis inducer, inducing a dose- and time-dependent apoptosis in H460 and H1792 cells References Certificates Categories Extra info W Roa et al. Enhancement of radiation sensitivity with BH3I-1 in non-small cell lung cancer. Clin. Invest. Med. 2005, 28(2), 55-63.? ? S Shangary and DE Johnson. Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 2003, 17, 1470–1481.? Certificate of Analysis Material Safety Data Sheet Apoptosis Cell Cycle Regulation Cell Signaling & Oncology Bcl Inhibitor of Bcl-2 family protein Chemical name 2-(5-(4-bromobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-3-methylbutanoic acid Parent CAS No. [300817-68-9] Order Size Unit Price Stock 10 mg €125.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
BH3I 1 - BHI 1Axon 1828 CAS [300817-68-9] MF C15H14BrNO3S2
Description
Cell permeable antitumor agent targeting Bcl-2 family protein, more specifically as Bcl-xL antagonist; apoptosis inducer, inducing a dose- and time-dependent apoptosis in H460 and H1792 cells
Inhibitor of Bcl-2 family protein
Chemical name2-(5-(4-bromobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-3-methylbutanoic acid Parent CAS No.[300817-68-9] |
| 產(chǎn)品資料 |
